MUHC in the Media - August 21, 2023
![The first pill for post-partum depression](/sites/default/files/muhc-in-news/imagees-2023-08/dr-tuong-vi-nguyen.jpg)
The first pill for post-partum depression
Zuranolone, the first pill specifically developed to treat post-partum depression, has just been approved in the United States. This is an exciting and promising step, says Dr. Tuong Vi Nguyen, a reproductive psychiatrist at the McGill University Health Centre. CBC
![Medical writing: caution warranted if using ChatGPT](/sites/default/files/muhc-in-news/imagees-2023-08/dr-esli-osmanlliu.jpg)
Medical writing: caution warranted if using ChatGPT
Researchers from CHU Sainte-Justine and the Montreal Children's Hospital recently asked ChatGPT 20 medical questions. The chatbot provided answers of limited quality (median score of 60 per cent), including a dozen actual errors, and 69 per cent of the references were fabricated, show the results of their study published in Mayo Clinic Proceedings: Digital Health. Dr. Esli Osmanlliu, co-author of the study, emergency physician at the Montreal Children's Hospital and scientist at the RI-MUHC, urges researchers to be vigilant. CityNews, CJAD, CHED
![Montreal researchers join international study of rare disease Friedreich's ataxia](/sites/default/files/muhc-in-news/imagees-2023-08/friedreich-ataxia.jpg)
Montreal researchers join international study of rare disease Friedreich's ataxia
Dr. Massimo Pandolfo of the Montreal Neurological Institute is among the experts collecting research about Friedreich's ataxia, a condition that causes progressive mobility limitations as well as other issues, including cardiac problems. The Canadian Press
![Young woman with rare cancer waits for RAMQ to fund out-of-province clinical trial](/sites/default/files/muhc-in-news/imagees-2023-08/young-woman-rare-cancer-waits-ramq.jpg)
Young woman with rare cancer waits for RAMQ to fund out-of-province clinical trial
Dr. Ramy Saleh, oncologist and medical director of oncology research at the MUHC, is trying to help his patient, a young mother with a rare sarcoma, join a potentially life-saving clinical trial in Calgary. CBC Montreal